Macquarie Group
-
Bain Capital and Cinven have agreed to buy Stada, the German generic pharmaceuticals firm, for €4.1bn, in what Dealogic shows is the biggest public-to-private buyout of a European company for four years.
-
Bain Capital and Cinven have agreed to buy Stada, the German generic pharmaceuticals firm, for €4.1bn, in the biggest private equity acquisition of a European company for four years.
-
Macquarie’s head of ECM origination for Asia has left the firm, sources close to the move have told GlobalCapital Asia.
-
Gates Global, the power transmission belts maker, held a lender call on Friday afternoon London time for a $300m-equivalent euro term loan ‘B’ add-on, having tapped its 2022 bonds on Thursday.
-
The equity market for Chinese education companies in Hong Kong is heating up, with Minsheng Education Group Co, the first pure play university IPO from the mainland, finishing bookbuilding this week to much success. All the signs show that investors are excited about the sector, writes Jonathan Breen.
-
Minsheng Education Group Co rapidly covered books for its Hong Kong IPO, which was launched on Wednesday and is expected to raise up to HK$1.5bn ($195.7m), according to a source close to the deal.
-
The heat is on for IPOs in south-east Asia, with banks staging charm offensives towards investors during pre-marketing.
-
China’s Minsheng Education Group has launched pre-deal investor education for its Hong Kong IPO that could raise up to $200m, according to bankers close to the deal.
-
Activity is trickling back into Asia ECM as bankers return to their desks post Chinese New Year, with several Hong Kong IPOs looking to start pre-marketing and a Thai name testing investor appetite.
-
Shares in UniCredit, Italy’s largest bank, closed 1.7% lower on Thursday after it unveiled the terms for its fully underwritten €13bn recapitalisation late on Wednesday.
-
Canaccord Genuity has hired an experienced ECM banker to be its head of UK and European equity capital markets.
-
Hebei Yichen Industrial Group Corp priced its Hong Kong IPO at the low end of its marketing range last week, netting HK$673.5m ($86.8m).